Skip to content

The improvement of endometrial receptivity in PCOS patients by Vitamin D3: a prospective randomized controlled clinical trial

The improvement of endometrial receptivity in PCOS patients by Vitamin D3: a prospective randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006369
Enrollment
Unknown
Registered
2015-05-08
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility

Interventions

Obesity-Placebo:Placebo for three months
Obesity-Vitamin D3:Vitamin D3 for three months
Non-obesity-Placebo:Placebo for three months
Non-obesity-Vitamin D3:Vitamin D3 for three months

Sponsors

First Affilited Hospital of Zhengzhou Univercity
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Vitamin deficiency (< 20 ng/mL); 2. Anovulatory patients with PCOS; 3. All patients were excluded from other endocrine disorders, and has not used hormone drugs for almost 3 months; 4. Age: 25-39.

Exclusion criteria

Exclusion criteria: 1. Malformation of uterus: such as uterus unicornis, uterus bicornis, untreated uterus septus, etc.; 2. History of endometrial diseases: such as intrauterine adhesion, uterine cavity tuberculosis, severe dysplasia of endometrium, etc.; 3. Multiple myomata or endometrioma which causes uterus oppression; 4. Multiple and recurrent endometrial polyps; 5. Pelvic tuberculosis, endometriosis.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;

Secondary

MeasureTime frame
Embryo implantation rate;Live birth rate;Miscarriage rate;Preterm birth rate;

Countries

China

Contacts

Public ContactLiang Wu
rbny@163.com+86 13203813873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026